Skip to the page

Data / Drug companies / Pantoprazole sodium

Pantoprazole sodium: 54 companies and 108 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Pantoprazole sodium is listed in the FDA National Drug Code Directory by 54 companies, with 108 products in commercial distribution. 97 of the products (89.8%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, delayed release; injection, powder, for solution; injection, powder, lyophilized, for solution, and the newest product started marketing on September 30, 2026.

The request: Get every company that lists pantoprazole sodium in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
54
Products
108
Generic (ANDA) products
97 (89.8%)
Application numbers
28
Routes
Oral, Intravenous
Brand names
Protonix I.V., Protonix Delayed-Release
openFDA record search
api.fda.gov

Companies that list pantoprazole sodium

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Cardinal Health 107, LLC10tablet, delayed release; injection, powder, for solutionGeneric drugs (ANDA)September 14, 2026
Advanced Rx of Tennessee, LLC6tablet, delayed releaseGeneric drugs (ANDA)June 27, 2024
Wyeth Pharmaceuticals LLC, a Subsidiary of Pfizer Inc.5tablet, delayed release; injection, powder, for solutionNew drug applications (NDA)May 1, 2013
A-S Medication Solutions4tablet, delayed releaseGeneric drugs (ANDA)September 28, 2012
NuCare Pharmaceuticals,Inc.4tablet, delayed releaseGeneric drugs (ANDA)September 28, 2012
American Health Packaging3tablet, delayed release; for suspensionGeneric drugs (ANDA)August 1, 2023
Bryant Ranch Prepack3tablet, delayed releaseGeneric drugs (ANDA)September 28, 2012
Major Pharmaceuticals3tablet, delayed releaseGeneric drugs (ANDA)October 7, 2024
NorthStar RxLLC3granule, delayed release; injection, powder, for solutionGeneric drugs (ANDA)March 1, 2026
Remedyrepack Inc.3tablet, delayed releaseGeneric drugs (ANDA)January 11, 2019
Asclemed USA, Inc.2tablet, delayed releaseGeneric drugs (ANDA)September 28, 2012
Aurobindo Pharma Limited2tablet, delayed releaseGeneric drugs (ANDA)September 28, 2012
AvPAK2tablet, delayed releaseGeneric drugs (ANDA)January 28, 2021
Camber Pharmaceuticals, Inc.2granule, delayed release; injection, powder, for solutionGeneric drugs (ANDA)October 27, 2023
Chartwell RX, LLC2tablet, delayed releaseGeneric drugs (ANDA)January 20, 2011
Coupler LLC2tablet, delayed releaseGeneric drugs (ANDA)June 1, 2026
Golden State Medical Supply, Inc.2tablet, delayed releaseGeneric drugs (ANDA)January 20, 2011
Granules Pharmaceuticals Inc.2tablet, delayed releaseGeneric drugs (ANDA)April 12, 2024
Hawaii Repack, Inc.2tablet, delayed releaseGeneric drugs (ANDA)September 28, 2012
Hikma Pharmaceuticals USA Inc.2injection, powder, lyophilized, for solutionNew drug applications (NDA)September 22, 2017
Lannett Company, Inc.2tablet, delayed releaseGeneric drugs (ANDA)January 20, 2011
Meitheal Pharmaceuticals Inc.2injection, powder, for solutionGeneric drugs (ANDA)August 29, 2022
Mylan Pharmaceuticals Inc.2tablet, delayed releaseGeneric drugs (ANDA)January 19, 2011
NCS HealthCare of Ky, LLC DBA Vangard Labs2tablet, delayed releaseGeneric drugs (ANDA)September 28, 2012
Northwind Health Company, LLC2tablet, delayed releaseGeneric drugs (ANDA)September 27, 2022
QPharma, Inc.2tablet, delayed releaseGeneric drugs (ANDA)September 28, 2012
Rising Pharma Holdings, Inc.2tablet, delayed releaseGeneric drugs (ANDA)March 12, 2025
Sun Pharmaceutical Industries, Inc.2granule, delayed release; injection, powder, lyophilized, for solutionGeneric drugs (ANDA)July 1, 2020
Torrent Pharmaceuticals Limited2tablet, delayed releaseGeneric drugs (ANDA)January 20, 2011
Unit Dose Solutions, Inc.2tablet, delayed releaseGeneric drugs (ANDA)July 1, 2026
Ajanta Pharma USA Inc.1for suspensionGeneric drugs (ANDA)February 9, 2023
Aphena Pharma Solutions - Tennessee, LLC1tablet, delayed releaseGeneric drugs (ANDA)January 20, 2011
Aurobindo Pharma Limited1granule, delayed releaseGeneric drugs (ANDA)March 31, 2025
Avenacy, LLC1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)September 30, 2026
Be Pharmaceuticals Inc.1injection, powder, for solutionGeneric drugs (ANDA)May 25, 2022
Bryant Ranch Prepack1tablet, delayed releaseGeneric drugs (ANDA)January 20, 2011
Burel Pharmaceuticals, LLC1tablet, delayed releaseGeneric drugs (ANDA)April 20, 2020
Civica, Inc.1injection, powder, lyophilized, for solutionNew drug applications (NDA)June 1, 2025
Devatis, Inc.1injection, powder, for solutionGeneric drugs (ANDA)August 1, 2025
Edenbridge Pharmaceuticals LLC.1granule, delayed releaseGeneric drugs (ANDA)June 16, 2023
Eugia US LLC1injection, powder, for solutionGeneric drugs (ANDA)March 30, 2016
Fresenius Kabi USA, LLC1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)August 1, 2024
Gland Pharma Limited1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)May 18, 2022
Mylan Institutional Inc.1tablet, delayed releaseGeneric drugs (ANDA)February 23, 2011
Novadoz Pharmaceuticals LLC1injection, powder, for solutionGeneric drugs (ANDA)May 19, 2022
PD-Rx Pharmaceuticals, Inc.1tablet, delayed releaseGeneric drugs (ANDA)January 20, 2011
Piramal Critical Care Inc1injection, powder, for solutionGeneric drugs (ANDA)October 10, 2023
Proficient Rx LP1tablet, delayed releaseGeneric drugs (ANDA)January 20, 2011
Quality Care Products, LLC1tablet, delayed releaseGeneric drugs (ANDA)July 18, 2023
Redpharm Drug1tablet, delayed releaseGeneric drugs (ANDA)September 28, 2012
Safecor Health, LLC1tablet, delayed releaseGeneric drugs (ANDA)March 13, 2026
Sagent Pharmaceuticals1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)July 15, 2022
Sandoz Inc1injection, powder, for solutionGeneric drugs (ANDA)January 26, 2026
Sun Pharmaceutical Industries, Inc.1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)April 3, 2023

Dosage forms

Dosage formProductsShare
Tablet, delayed release7569.4%
Injection, powder, for solution1513.9%
Injection, powder, lyophilized, for solution109.3%
Granule, delayed release65.6%
For suspension21.9%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)9789.8%
New drug applications (NDA)1110.2%

Pharmacologic classes

ClassProducts
Proton Pump Inhibitor108

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.